ResearcherHarvard UniversityActive in the last 2 years
Abraham Fourie Bezuidenhout
Matched on ORCID iD 0000-0002-2133-5171; OpenAlex author ID A5085203553. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 34
2022: 1 paper · 2023: 3 papers · 2024: none · 2025: none · 2026: 2 papers
Papers 6
- CT imaging findings following treatment with combination SBRT and chemotherapy versus stand-alone chemotherapy for locally advanced pancreatic adenocarcinoma. First author DOI 10.1007/s00261-025-05066-9↗
- Patient experience with endoscopic ultrasound and magnetic resonance cholangiopancreatography for pancreatic cancer screening (The PATRIOT study). Co-author DOI 10.1016/j.pan.2025.12.024↗
- Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of ab… Co-author DOI 10.1007/s00261-022-03693-0↗
- Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey. Co-author DOI 10.1016/j.hpb.2023.07.883↗
- Unexplained Acute Distal Pancreatitis: Association With Subsequent Diagnosis of Pancreatic Cancer. Co-author DOI 10.2214/ajr.23.28999↗
- Incidence of pancreatic cancer during long-term follow-up in patients with incidental pancreatic cysts smaller than 2 cm. Co-author DOI 10.1007/s00330-021-08428-1↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Olga Rachel Brook · 4 shared papers, 2022–2026 · strength 0.83
- Paper CT imaging findings following treatment with combination SBRT and chemotherapy versus stand-alone chemotherapy for loca… DOI 10.1007/s00261-025-05066-9↗
- Paper Unexplained Acute Distal Pancreatitis: Association With Subsequent Diagnosis of Pancreatic Cancer. DOI 10.2214/ajr.23.28999↗
- Paper Incidence of pancreatic cancer during long-term follow-up in patients with incidental pancreatic cysts smaller than 2 c… DOI 10.1007/s00330-021-08428-1↗
- Andy Silva-Santisteban · 1 shared paper, 2026 · strength 0.36
- Mandeep Sawhney · 1 shared paper, 2026 · strength 0.36
- Vishaal Gudla · 1 shared paper, 2026 · strength 0.32
- Bettina Siewert · 1 shared paper, 2026 · strength 0.32
- Matthew J. Abrams · 1 shared paper, 2026 · strength 0.32
- Steven D. Freedman · 1 shared paper, 2023 · strength 0.20
- Leo L. Tsai · 1 shared paper, 2023 · strength 0.20
- Masoud Nakhaei · 1 shared paper, 2022 · strength 0.19
- Victoria Chernyak · 1 shared paper, 2022 · strength 0.19
- Zhen J. Wang · 1 shared paper, 2023 · strength 0.12
- Alexander Savio Ramos Guimaraes · 1 shared paper, 2023 · strength 0.12
- Michael Hayden Rosenthal · 1 shared paper, 2023 · strength 0.12
- Ott Le · 1 shared paper, 2023 · strength 0.12
- Marc Zins · 1 shared paper, 2023 · strength 0.12
- Jin Peng He · 1 shared paper, 2023 · strength 0.12
- Eric Peter Tamm · 1 shared paper, 2023 · strength 0.12
- Samuel Joseph Galgano · 1 shared paper, 2023 · strength 0.12
- Lyndon Luk · 1 shared paper, 2023 · strength 0.12
- Erik V. Soloff · 1 shared paper, 2023 · strength 0.12
- Naveen M. Kulkarni · 1 shared paper, 2023 · strength 0.12
- Lorenzo Mannelli · 1 shared paper, 2023 · strength 0.12
- Candice W. Bolan · 1 shared paper, 2023 · strength 0.12
- Parag P. Tolat · 1 shared paper, 2023 · strength 0.12
- Priya Bhosale · 1 shared paper, 2023 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.